Results 151 to 160 of about 212,589 (324)
Abstract Objective To compare surgical and oncologic outcomes between conventional resectoscopic surgery and mechanical hysteroscopic tissue removal (mHTR) systems in high‐risk patients not suitable for standard surgery undergoing conservative treatment for multifocal endometrial atypical hyperplasia/endometrial intraepithelial neoplasia (EAH/EIN) or ...
Alessandro Arena+9 more
wiley +1 more source
Surgical site infections and sepsis in gynecological surgery
Abstract Despite advancements in infection control, surgical site infections (SSIs) and postoperative sepsis remain significant challenges in gynecological surgery, contributing to increased morbidity, mortality, and healthcare costs. In low‐income countries, circulatory failure due to septic shock leads to most deaths after surgery, with sepsis ...
Cristina Taliento+13 more
wiley +1 more source
Postoperative Deep Vein Thrombosis in the Lower Extremity Amputee
Robert W. Barnes, Earlene E. Slaymaker
openalex +2 more sources
We found that the joint prediction model was better than the total cholesterol, low‐density lipoprotein cholesterol, modified computed tomography severity index score and liver computed tomography value, alone in assessing the performance of non‐mild hypertriglyceridemia‐induced acute pancreatitis, which can predict the severity of hypertriglyceridemia‐
Junyao Long+4 more
wiley +1 more source
CAQ Corner: Immune‐mediated complications
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
THE PREVENTION OF DEEP VEIN THROMBOSIS AFTER SURGERY
James Calnan, F. Allenby
openalex +1 more source
Postoperative Changes in the Plasmatic Levels of Tissue-Type Plasminogen Activator and Its Fast-Acting Inhibitor - Relationship to Deep Vein Thrombosis and Influence of Prophylaxis [PDF]
José A. Páramo+2 more
openalex +1 more source
Research and scholarly methods: Mitigating information bias
Abstract Whether designing a research study or considering changes to a patient's medication therapy based on published research, pharmacists must be knowledgeable about potential sources of bias in clinical research and how these threats to internal validity can be mitigated.
Gary L. Cochran+2 more
wiley +1 more source